To retrospectively review the efficacy and safety of endoscopic sinus surgery (ESS) without postoperative nasal packing for the treatment of chronic rhinosinusitis (CRS). METHOD: Charts were reviewed from 154 patients with CRS who underwent ESS without postoperative nasal packing or the use of hemostatic agents at the conclusion of surgery. Operative blood loss, postoperative sinonasal pain assessed via a visual analog scales (VAS) from 0-10, surgical outcome, and the incidence of postoperative complications such as bleeding were reviewed. RESULTS: Seventy-one women and 83 men with a mean age of 45.5 years were included in the study. Mean estimated operative blood loss was 128.3 mL (range: 10-650). Epiphora and eye discomfort/pressure were present in 14 (9.1%) and 10 (6.5%) patients, respectively. Mean VAS for sinonasal pain was 0.98. Two subjects (1.3%) experienced primary postoperative bleeding requiring nasal packing with petroleum gauze for 1 and 3 days, respectively. No delayed nasal bleeding or other serious complications occurred. The recurrence rate of CRS was 5.8% (9/154). Two patients underwent revised ESS. CONCLUSION: ESS without postoperative nasal packing is feasible and safe.
Efficacy of Herbal Treatment for Olfactory Dysfunction
Kojiro Hirano, MD (presenter); Yasuyuki Hinohira, MD, PhD; Jun Uchida, MD, PhD; Harumi Suzaki, MD, PhD OBJECTIVE: 1) Evaluate the efficacy of Chinese herbal medicine for patients with severe olfactory dysfunction using T & T olfactometer. 2) Establish the indication of the novel therapy. METHOD: 121 patients diagnosed as severe olfactory dysfunction caused by the olfactory epithelial disorders were subjected to this study. All of them were refractory for prior medical treatments including a topical nasal drop of adrenocortical hormone. They consisted of 35 males and 86 females, and the ages of the patients ranged 26 to 83. They were randomly divided into two groups according to kinds of Chinese herbal medicines such as 'ninnjinnyoueitou (N)' or 'toukishakuyakusann (T).' The two groups were treated by internal use of the medicines for 3 to 6 month, respectively. They were evaluated as Fine, Improvement, or Unchanged after the treatment, using T & T olfactometer. RESULTS: 28% of the N group showed Fine and 6% Improvement although 65% of them showed Unchanged. The T group showed that Fine is 3% and Improvement 38%. 30 to 40% of the patients subjected to this study showed at least improvement in their olfactory function. There was no signif-icant difference between both groups. No patients encountered any complications. CONCLUSION: It has been reported that only a topical steroid nasal drop is effective for the patients diagnosed as severe olfactory dysfunction caused by the olfactory epithelial disorders. Our study indicated that Chinese herbal treatments have certain efficacy for the patients, who were refractory for prior medical treatments including a topical steroid nasal drop.
Efficacy of Intrathecal Fluorescein in CSF Leak Repair
Pete Batra, MD (presenter); Karthik Rajasekaran, MS, III OBJECTIVE: To evaluate the utility of intrathecal fluorescein for intraoperative localization and successful repair of cerebrospinal fluid (CSF) leaks. METHOD: Retrospective chart review was performed from 1999 to 2009 at a tertiary care medical center. Informed consent was obtained from all patients undergoing intrathecal fluorescein administration (total dose 10 mg) during CSF leak repair. RESULTS: A total of 105 patients underwent CSF leak repair. Mean age was 49.9 years and 69 were female (65.7%). The most frequent etiologies of CSF leak were spontaneous (37.1%), skull base tumor resection (35.2%), and iatrogenic injury (18.1%). Fluorescein was used in 49 cases (46.7%). Fluorescein was visualized in 31 cases of active CSF leaks (63.3%), while 11 (22.4%) had leaks without fluorescein, and 7 (14.3%) did not have leaks or fluorescein. Sensitivity and specificity for fluorescein detection was 73.8% and 100%, respectively. Cribriform plate (65.2%), sphenoid lateral recess (72.7%), and central sphenoid (75.0%) leaks had a higher fluorescein visualization rate than ethmoid roof (25.0%) (pϭ0.12). Factors such as age, BMI, and previous history of meningitis did not impact the ability to detect fluorescein during leak repair. Recurrence rates were slightly higher among patients in whom fluorescein was not visualized (10.2% versus 6.1%, pϭ0.12). No complications arose from use of fluorescein with our standard administration protocol. CONCLUSION: Intrathecal fluorescein may be useful in the ability to accurately localize CSF leaks, with sensitivity and specificity of 73.8% and 100%, respectively. Recurrence rates are slightly higher if fluorescein is not visualized, though this did not reach statistical significance.
